Enhancing Methotrexate Effectiveness with Nucleoside Transport Inhibitors
Author Information
Author(s): J.M. Hughes, M.H.N. Tattersall
Primary Institution: University of Sydney
Hypothesis
Can nucleoside transport inhibitors enhance the cytotoxicity of methotrexate in lymphocytes?
Conclusion
Nucleoside transport inhibitors like dipyridamole significantly enhance the cytotoxic effects of methotrexate on lymphocytes in vitro.
Supporting Evidence
- Dipyridamole abolished thymidine uptake and potentiated methotrexate cytotoxicity.
- 555 was less potent than dipyridamole but still enhanced methotrexate effects.
- High-density lymphocyte growth was unaffected by dipyridamole.
Takeaway
This study shows that certain drugs can help make cancer treatments more effective by blocking how cells take in nutrients that protect them from the medicine.
Methodology
The study involved culturing lymphocytes and testing the effects of nucleoside transport inhibitors on methotrexate cytotoxicity.
Limitations
The study was conducted in vitro, which may not fully represent in vivo conditions.
Participant Demographics
Lymphocytes from normal volunteers and single donor white cell concentrates were used.
Want to read the original?
Access the complete publication on the publisher's website